title: [The place of a new drug in the therapeutic strategy].
abstract: A therapeutic strategy is a hierarchical set of appropriate measures to provide an answer to a pathological state. A drug is a part of this set (together with the diagnosis, the environment and the other medicinal interventions or not). A new drug's place in a therapeutic strategy can be evaluated according to one or several referential(s) when it (or they) exist, referentials which express the state of knowledge before launch of the new drug. The drug's profile (indication or contraindication, etc.), at the point when the marketing authorization is given, is purely theoretical. One must evaluate the real place of the drug under its real conditions of use (pragmatic trials, observable surveys). A new drugs' place in a therapeutic strategy can only be evaluated in the course of time unless a therapeutic revolution occurs.
authors.affiliation: CHU Henri Mondor, Service de Cardiologie, Créteil, France.
authors.forename: A
authors.initials: A
authors.lastname: Castaigne
authors.forename: J M
authors.initials: JM
authors.lastname: Goehrs
authors.forename: S
authors.initials: S
authors.lastname: Ravoire
mesh_terms: D019090:Case Management; D004341:Drug Evaluation; D004345:Drug Industry; D004358:Drug Therapy / Q000379:methods*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000191:economics; D010818:Practice Patterns, Physicians'
chemical_list: D004364:Pharmaceutical Preparations